AMPK activation directly phosphorylates PD-L1 (S195) and triggers abnormal PD-L1 glycosylation and endoplasmic-reticulum-associated degradation of PD-L1 [38], which promotes the immune surveillance of CD8(+) cytotoxic T cells and suppresses breast tumor progression. Here, CD274 is linked to breast neoplasm.